Zorevunersen: Hope for Dravet Syndrome Kids

0:00A March 4, a groundbreaking drug called Zora Vooner Sin, is bringing hope to kids with dravet syndrome, a severe epilepsy caused by a faulty gene. This condition hits early in life and leads to non-stop seizures that can cause serious injury or worse, without good treatment. The drug targets the root problem by boosting healthy brain signals and is given through an injection into the spine. Early trials show it works well for children, as young as two, cutting seizures by up to 90% in many cases. Researchers published promising safety data in the New England Journal of Medicine, with tests done in the U.S. and U.K. hospitals like Great Ormond, Street. Families are thrilled with the changes. Take eight-year-old Freddie from Huddersfield, one of the first in the U.K. to try it. He went from hundreds of seizures a day to just a couple a week, letting him hike, ski, and play outside with his family. In U.K. kids, join the 81-person study, and many, including Freddie, keep getting doses for more research.

1:00Experts from University College, London, call the results, exciting steps toward normal lives. As phase three trials gear up, this treatment could soon offer real relief to thousands of families facing dravet syndrome every day.